Alphapharm says Sanofi patent amendment should doom injunction bid

Christian Dimitriadis 2018-08-30 9:13 pm By Miklos Bolza | Sydney

Please login to bookmark

Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au